Corient Capital Partners’s Amdocs DOX Stock Holding History

Corient Capital Partners’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$213K	Hold	2,551	–	–	0.02%	594
2022 Q2	$213K	Buy	+2,551	New	+$210K	0.02%	607

Other funds holding DOX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Corient Capital Partners's DOX Position: Q3 2022 in Review

Corient Capital Partners held its Amdocs (DOX) position steady in Q3 2022 at 2,551 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #594.

Corient Capital Partners first reported a position in DOX in Q2 2022 and has held it in 2 quarters since. 450 funds tracked by Wall St. Rank hold DOX as of Q3 2022.

Corient Capital Partners held 2,551 shares of Amdocs worth $213K as of Q3 2022.
Corient Capital Partners left its Amdocs share count unchanged in Q3 2022.
Amdocs made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #594 holding.
Corient Capital Partners first reported a position in Amdocs in Q2 2022 and has held it in 2 quarters since.
450 funds tracked by Wall St. Rank held Amdocs as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.